DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 23 filers reported holding DIAMEDICA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $906,000 | -88.6% | 203,641 | -76.6% | 0.49% | -83.3% |
| Q1 2021 | $7,963,000 | -2.7% | 870,228 | +7.8% | 2.93% | +50.5% |
| Q4 2020 | $8,182,000 | +164.4% | 806,900 | +10.5% | 1.95% | +24.2% |
| Q3 2020 | $3,095,000 | +121.9% | 730,000 | +262.7% | 1.57% | +73.6% |
| Q2 2020 | $1,395,000 | – | 201,248 | – | 0.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 325,000 | $1,404,000 | 2.87% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 198,730 | $858,514 | 0.97% |
| Bleichroeder LP | 294,117 | $1,270,585 | 0.26% |
| EAM Investors, LLC | 270,419 | $1,168,210 | 0.22% |
| COOPERMAN LEON G | 875,993 | $3,784,290 | 0.20% |
| CATALYST FINANCIAL PARTNERS LLC | 36,267 | $156,673 | 0.06% |
| Legend Financial Advisors, Inc. | 1,000 | $4,320 | 0.00% |
| FIRST MANHATTAN CO. LLC. | 124,744 | $538,894 | 0.00% |
| Tower Research Capital LLC (TRC) | 6,240 | $26,957 | 0.00% |
| MASSMUTUAL TRUST CO FSB/ADV | 4,824 | $20,840 | 0.00% |